Core Viewpoint - CloudTop New Drug (01952) has achieved a significant milestone in its patent protection for Budesonide Enteric Capsules (Nai Fu Kang), with the Guangzhou Intellectual Property Court ruling in favor of the company's pre-litigation preservation request, ordering relevant generic drug companies to cease infringement immediately [1] Group 1 - The Guangzhou Intellectual Property Court issued a civil ruling on February 26, 2026, fully supporting the company's request for pre-litigation preservation [1] - The court's ruling mandates that the infringing generic drug companies stop their infringement activities and remove their products from the market immediately [1] - CloudTop New Drug welcomes the court's fair ruling and emphasizes its commitment to protecting intellectual property rights and promoting innovative therapies for more patients [1]
云顶新耀耐赋康 专利维权取得积极进展